GlassScriptPhysician profile
Lisa Marie Chute
NPI 1639690712
$8,793.71
in general payments reported to CMS, 2019-2025
22 companies · $1,535 in 2025
The $1,535 reported for 2025 was more than what 95% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2020: $228 · 2021: $714 · 2022: $887 · 2023: $3,204 · 2024: $1,856 · 2025: $1,535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,755 · Travel and Lodging: $2,839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,755.45 |
| Travel and Lodging | $2,839.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $1,996.66 | 2019-2024 | |
| Bausch & Lomb Americas INC. | $1,747.44 | 2022-2025 | Miebo, Xiidra, Infuse |
| Coopervision INC. | $972.79 | 2020-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Lumenis Be INC | $610.63 | 2025 | Optilight |
| Sun Pharmaceutical Industries INC. | $609.89 | 2021-2025 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $576.97 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $523.19 | 2019-2024 | Acuvue |
| Sight Sciences, INC. | $336.17 | 2022-2025 | Tearcare System, Omni Surgical System |
| Alcon Vision LLC | $323.70 | 2021-2025 | Precision 1, Tryptyr, Total30 |
| Tarsus Pharmaceuticals, INC. | $218.63 | 2024-2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $164.84 | 2021 | |
| Oyster Point Pharma, INC. | $156.99 | 2022-2023 | Tyrvaya |
| Shire North American Group INC | $152.81 | 2019 | |
| Astellas Pharma US INC | $136.09 | 2023-2025 | Izervay |
| Lkc Technologies, INC. | $121.84 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $42.93 | 2021-2022 | |
| Abb Con-Cise Optical Group LLC | $22.92 | 2021 | |
| Harrow Eye, LLC | $18.45 | 2025 | Vevye |
| Topcon Healthcare, INC. | $16.64 | 2024 | |
| Allergan, INC. | $15.73 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $15.64 | 2019 | |
| Abbvie INC. | $12.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Chute listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.